1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Italy Pharmaceuticals and Healthcare Report Q1 2016

Italy Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View:

While the implementation of cost containment policies targeting the pharmaceutical industry inItaly may work to prevent the healthcare expenditure budget from overshooting, in the long term, suchpolicies may lower incentives for structural reforms of the healthcare sector as in theory they do notguarantee the efficient provision and management of healthcare services. The Italian public sector operatesthrough regional autonomous communities, resulting in a decentralised approach to drug procurement andhealthcare provision.

Headline Expenditure Projections

- Pharmaceuticals: EUR22.04bn (USD29.53bn) in 2014 to EUR21.74bn (USD23.92bn) in 2015; -1.3% inlocal currency terms and -19.0% in US dollar terms.

- Healthcare: EUR141.35bn (USD189.40bn) in 2014 to EUR141.28bn (USD155.41bn) in 2015; flatexpenditure in local currency terms and -17.9% in US dollar terms.

Table Of Contents

Italy Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View ... 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Italy 2013-2019) . 7
SWOT 9
Industry Forecast .. 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Italy 2011-2019) 11
Healthcare Market Forecast .. 12
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2011-2019) . 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2011-2019) . 14
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2011-2019) . 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Italy 2011-2019) . 17
Patented Drug Market Forecast . 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Italy 2011-2019) . 19
Generic Drug Market Forecast .. 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Italy 2011-2019) 22
OTC Drug Market Forecast ... 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Italy 2011-2019) . 24
Pharmaceutical Trade Forecast . 25
Table: Pharmaceutical Trade Data And Forecasts (Italy 2013-2019) . 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Italy 2013-2019) . 27
Industry Risk Reward Index . 28
Western Europe Risk/Reward Index 28
Italy Risk/Reward Index 34
Rewards ... 34
Risks 34
Regulatory Review 35
Intellectual Property Issues .. 36
Pricing Regime .. 38
Reimbursement Regime ... 41
Market Overview ... 44
Healthcare Sector .. 44
Table: Healthcare Resources (Italy 2009-2014) 45
Table: Healthcare Personnel (Italy 2009-2014) 45
Table: Healthcare Activity (Italy 2009-2014) 46
Research and Development 46
Clinical Trials ... 47
Epidemiology 48
Competitive Landscape 50
Research-Based Industry . 50
Table: Multinational Market Activity . 51
Pharmaceutical Distribution 51
Pharmaceutical Retail Sector ... 52
Company Profile 54
GlaxoSmithKline . 54
Menarini 56
Novartis . 59
Pfizer 62
Recordati ... 65
Demographic Forecast . 68
Table: Population Headline Indicators (Italy 1990-2025) . 69
Table: Key Population Ratios (Italy 1990-2025) . 69
Table: Urban/Rural Population and Life Expectancy (Italy 1990-2025) 70
Table: Population By Age Group (Italy 1990-2025) . 70
Table: Population By Age Group % (Italy 1990-2025) 71
Glossary . 73
Methodology .. 75
Pharmaceutical Expenditure Forecast Model .. 75
Healthcare Expenditure Forecast Model . 75
Notes On Methodology 76
Risk/Reward Index Methodology ... 77
Index Overview .. 78
Table: Pharmaceutical Risk/Reward Index Indicators . 78
Indicator Weightings .. 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.